Effect of shensongyangxin capsule on myocardial remodeling and ventricular fibrillation threshold value in rat with coronary artery ligation

Zhongguo Zhongyao Zazhi

Volumn 34, Issue 16, 2009, Pages 2101-2104

  Chai, Songbo ^a   Wang, Shuoren ^a   Yao, Lifang ^b   Wu, Aiming ^a   Liu, Yuxin ^a   Rao, Chunmei ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b XIYUAN HOSPITAL   (China)

Author keywords

Coronary artery ligation; Echocardiogram; Ventricular fibrillation threshold value; Ventricular remodeling

Indexed keywords

AMIODARONE; CHINESE DRUG; SHENSONGYANGSIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DOPPLER ECHOCARDIOGRAPHY; DRUG CAPSULE; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE VOLUME; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE REMODELING; HEART VENTRICLE SEPTUM; MALE; NONHUMAN; RAT;

ANIMALS; CAPSULES; CORONARY VESSELS; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; HEART; HUMANS; LIGATION; MALE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; VENTRICULAR FIBRILLATION; VENTRICULAR REMODELING;

EID: 70449117632     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators: preliminary report: effect of encainde and flecainide on mortality in a randomized trial of arrhythmic suppression after myocardial infartion[J]. N Engl J Med, 1989, 321:406.